We are pleased to announce that we have received 510(k) clearance from the FDA for the expanded T2Bacteria® Panel, adding the capability to detect another bacterial species, Acinetobacter baumannii, to the expansive panel. https://t.co/SaNqAQcHgi
In a #publichealth emergency involving #biothreat pathogens, rapid and accurate diagnostic testing is expected to play a central role in achieving targeted antimicrobial treatment, improving patient outcomes, and minimizing economic impact. #T2Biothreat https://t.co/dFonBpN7Bh
We are pleased to announce that the T2Biothreat Panel has received 510(k) clearance from the FDA. This biothreat panel is the first and only FDA-cleared product able to simultaneously detect these six high-priority biothreat pathogens. https://t.co/zbpa22vscb
September is #SepsisAwarenessMonth. Sadly, in the 20 seconds it takes you to read this post, another person in the United States will be diagnosed with #sepsis. @SepsisAlliance is asking everyone to take the TIME to save a life. Learn more at https://t.co/yYcUzwjhMT. #SAM2023
We applaud @CDCgov for taking action to address the #sepsis crisis plaguing hospitals. The newly released Hospital Sepsis Program Core Elements is intended to help hospitals implement, monitor, and optimize sepsis programs and improve survival rates. https://t.co/PvWFALrwxt
If all 51,000 followers on stocktwits adds $300 to their portfolio tomorrow, that's $15M or over 40M shares! That will add tons of fuel to the fire when shorts cover tomorrow $TOO. TTOO army strong? We will see!